Search Results - "Ledinek, Alenka Horvat"

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease by Berger, Thomas, Adamczyk-Sowa, Monika, Csépány, Tünde, Fazekas, Franz, Fabjan, Tanja Hojs, Horáková, Dana, Ledinek, Alenka Horvat, Illes, Zsolt, Kobelt, Gisela, Jazbec, Saša Šega, Klímová, Eleonóra, Leutmezer, Fritz, Rejdak, Konrad, Rozsa, Csilla, Sellner, Johann, Selmaj, Krzysztof, Štouracˇ, Pavel, Szilasiová, Jarmila, Turcˇáni, Peter, Vachová, Marta, Vanecková, Manuela, Vécsei, László, Havrdová, Eva Kubala

“…At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and 2019 factors influencing daily treatment choices in MS, especially…”
Get full text

Parkinson's disease in a patient with multiple sclerosis and heterozygous glucocerebrosidase gene mutation by Delalić, Sentilija, Rus, Tomaž, Horvat Ledinek, Alenka, Kojović, Maja, Georgiev, Dejan

“…More than 30 patients with multiple sclerosis (MS) and Parkinson's disease (PD) have been reported so far. Theories on the co-occurrence of MS and PD range…”
Get full text

Local immunosuppression in ofatumumab: a series of three cases with bacterial infections near the injection sites by Bernik, Rok, Horvat Ledinek, Alenka, Brecl Jakob, Gregor

Get full text

Progressive multifocal leukoencephalopathy in association with siponimod treatment for secondary progressive multiple sclerosis: a case report by Rot, Uroš, Jerala, Miha, Horvat Ledinek, Alenka, Brecl Jakob, Gregor

Get full text

Psoriasis caused by ocrelizumab in two persons with primary progressive multiple sclerosis by Jakob Brecl, Gregor, Gabelić, Tereza, Ruška, Berislav, Horvat Ledinek, Alenka, Habek, Mario

Get full text

Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study by Habek, Mario, Jakob Brecl, Gregor, Bašić Kes, Vanja, Rogić, Dunja, Barun, Barbara, Gabelić, Tereza, Emeršič, Andreja, Horvat Ledinek, Alenka, Grbić, Nevena, Lapić, Ivana, Šegulja, Dragana, Đurić, Koraljka, Adamec, Ivan, Krbot Skorić, Magdalena

“…To determine the influence of high-efficacy disease modifying therapy (DMT) on the development of IgG SARS-CoV-2 antibody response in COVID-19 convalescent…”
Get full text

Transverse myelitis following COVID-19: Insights from a multi-center study and systematic literature review by Adamec, Ivan, Brecl Jakob, Gregor, Drulović, Jelena, Sellner, Johann, Bilić, Ervina, Sitaš, Barbara, Bilić, Hrvoje, Tamaš, Olivera, Budimkić, Maja, Veselinović, Nikola, Horvat Ledinek, Alenka, Jerše, Jana, Gomezelj, Sarah, Hauer, Larissa, Krbot Skorić, Magdalena, Habek, Mario

“…We aimed to provide insights into transverse myelitis (TM) following COVID-19 by analyzing cases treated at tertiary care neurology centers and a systemic…”
Get full text

Effectiveness and safety of alemtuzumab in the treatment of active relapsing–remitting multiple sclerosis: a multicenter, observational study by Brecl Jakob, Gregor, Barun, Barbara, Gomezelj, Sarah, Gabelić, Tereza, Šega Jazbec, Saša, Adamec, Ivan, Horvat Ledinek, Alenka, Rot, Uroš, Krbot Skorić, Magdalena, Habek, Mario

“…Objective So far, a limited number of real-world evidence studies about the effectiveness and safety of alemtuzumab (ALM) have been published, some of them…”
Get full text

Diffuse large B cell lymphoma mimics myasthenia gravis by Rutar Gorišek, Veronika, Zupančič, David, Zidar, Janez, Horvat Ledinek, Alenka

Get full text

Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis by Emeršič, Andreja, Karikari, Thomas K., Kac, Przemysław R., Gonzalez-Ortiz, Fernando, Dulewicz, Maciej, Ashton, Nicholas J., Brecl Jakob, Gregor, Horvat Ledinek, Alenka, Hanrieder, Jörg, Zetterberg, Henrik, Rot, Uroš, Čučnik, Saša, Blennow, Kaj

“…•Recent neuropathological studies suggest a possible contribution of tau pathology in MS progression.•We applied ultrasensitive quantification of different CSF…”
Get full text

Unilateral brachial plexopathy, a rare complication of Mycoplasma pneumoniae infection by Robnik, Barbara, Keše, Darja, Rojko, Tereza, Horvat-Ledinek, Alenka, Pražnikar, Aleš, Beović, Bojana

“…Few reports in the literature describe isolated peripheral neuropathies in relation to Mycoplasma pneumoniae infection without concurrent damage to the central…”
Get full text

Management of infusion related reactions associated with alemtuzumab in patients with multiple sclerosis by Šega-Jazbec, Saša, Barun, Barbara, Horvat Ledinek, Alenka, Fabekovac, Višnja, Krbot Skorić, Magdalena, Habek, Mario

“…Infusion-associated reactions (IARs) occur in >90% patients with multiple sclerosis (MS) treated with alemtuzumab. We aimed to study the frequency of IARs at 2…”
Get full text

Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis by Horvat Ledinek, Alenka, Brecl Jakob, Gregor, Jerše, Jana, Ruška, Berislav, Pavičić, Tin, Gabelić, Tereza, Barun, Barbara, Adamec, Ivan, Rot, Uroš, Šega Jazbec, Saša, Krbot Skorić, Magdalena, Habek, Mario

“…•There was no association between IVIG/no-IVIG and ARR one year after the delivery.•We found no predictors of postpartum relapses in women with RRMS.•We…”
Get full text

Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis by Rot, Uroš, Ledinek, Alenka Horvat, Jazbec, Saša Šega

“…Abstract Objectives The vast majority of clinically isolated syndrome (CIS) patients with at least two silent brain MRI lesions progress to multiple sclerosis…”
Get full text

Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients by Pavsic, Katja, Pelicon, Katarina, Ledinek, Alenka Horvat, Sega, Sasa

“…Highlights • Fampridine is licensed to improve walking in all types of multiple sclerosis. • We examined fampridine's impact on various functions besides…”
Get full text

Evaluating the effects of amantadin, modafinil and acetyl- l -carnitine on fatigue in multiple sclerosis – result of a pilot randomized, blind study by Ledinek, Alenka Horvat, Sajko, Mojca Cizek, Rot, Uros

“…Abstract Objective Fatigue affects more than 60% of multiple sclerosis (MS) patients and is one of the most troublesome symptoms of the disease. Current…”
Get full text

Intravenous Immunoglobulins for the Prevention of Postpartum Relapses in Multiple Sclerosis (94) by Ledinek, Alenka Horvat, Brecl, Gregor Jakob, Jerse, Jana, Ruska, Berislav, Pavicic, Tin, Gabelic, Tereza, Barun, Barbara, Adamec, Ivan, Rot, Uros, Jazbec, Sasa Sega, Skoric, Magdalena Krbot, Habek, Mario

“…Abstract only…”
Get full text

Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis by Rot, Uroš, Ledinek, Alenka Horvat

“…Abstract A 31-year-old woman with MS developed livedo reticularis and secondary Raynaud phenomenon 2.5 years after introduction of interferon beta-1b. The…”
Get full text

THE ROLE OF NURSING CARE IN TREATMENT OF PATINTS WITH INCONTINENCE - Neurologic Urinary Incontience by Horvat Ledinek, Alenka

Get full text

Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants by Kokas, Zsófia, Járdánházy, Anett, Sandi, Dániel, Biernacki, Tamás, Fricska-Nagy, Zsanett, Füvesi, Judit, Bartosik-Psujek, Halina, Kes, Vanja Basic, Berger, Thomas, Berthele, Achim, Drulovic, Jelena, Hemmer, Bernhard, Horakova, Dana, Ledinek, Alenka Horvat, Havrdova, Eva Kubala, Magyari, Melinda, Rejdak, Konrad, Tiu, Cristina, Turcani, Peter, Klivényi, Péter, Kincses, Zsigmond Tamás, Vécsei, László, Bencsik, Krisztina

“…•First assessment on real-world operation of MS centres in Central-Eastern Europe•A self-report questionnaire was used to assess MS care unit…”
Get full text